ADH1A and familial pancreatic carcinoma: In recent studies ADH-1 synthetic cyclic peptide, which mimics the natural HAVD sequence of N-cadherin, has been used in myeloma, neuroblastoma and pancreatic cancer in vitro [118,119,120].